Stratatech Corporation
MADISON, WI · CIK 0001161468 · Medtech · Acquired
Acquisition and operation of skilled trade schools
stratatech.com →- Grants
- $1000K
- 1 award
- Sector median: 1
- Raised
- $3.0M
- 1 Form D · Apr 2010
- 198 months since last filing
- Contracts
- $98M
- 8 awards · Defense, Health and Human S
- #11 of 4531 in medtech
- Patents
- 40
- 11 granted · 29 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200620082010201220142016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · Phase I SBIR | $849,352 | |
| Federal contract | Department of Defense · SBIR Phase I Osd 2009.3 Log 10020001 | $99,983 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Federal contract | Department of Defense · Stratatest ST24 Test Tissue Ki | $10,560 | |
| Federal contract | Department of Health and Human Services · TAS::75 0862::TAS 3D Skin Model W/enhanced Sensivity&throughput | $178,327 | |
| Federal contract | Department of Defense · #11271008 Tatrc SBIR Phase I P | $1,149,924 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf For Other Functionsdevelopment Of Stratagraft, A Living Cell-based Tissue With Characteristics Similar To Human Skin. | $17,785,895 | |
| Federal grant | Department of Defense · Phase II · Skin Substitute Technology for Chimeric Autologous/Allogeneic Constructs for Skin Regeneration - Preclinical Studies | $999,957 | |
| Federal contract | Department of Health and Human Services · Cell Based Skin Subs For Definitive Care Of Burn Injuries | $75,284,563 | |
| Federal contract | Department of Defense · Igf::ot::igf Phase 2 Clinical Trial - Stratagraft - Performance Of A Phase 2 Clinical Trial To Evaluate Safety And Efficacy Of An Allogeneic Skin Substitute Containing Both An Epidermal And Dermal Layer For The Treatment Of Complex, Full-thickness Skin Injuries | $2,730,436 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 8 | Foundation Medicine, Inc. | $158M | $59M |
| 9 | Inbios International Inc | $146M | — |
| 10 | Crossject SA | $104M | $10M |
| 11 | Stratatech Corporation | $98M | $3.0M |
| 12 | RAPISCAN LABORATORIES, INC. | $68M | — |
| 13 | SELUX DIAGNOSTICS, INC. | $63M | $124M |
| 14 | BANYAN BIOMARKERS, INC. | $62M | $14M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- B. Allen-Hoffmann, PhDDirector · Executive Officer
- Robert BarnardExecutive Officer
- Joseph Davie, MD, PhDDirector
- F. HoffmannDirector
- Tod LinstrothExecutive Officer
- Benjamin Montgomery, MDDirector
Patents
- Allogeneic Cultured Keratinocyte Productsapplication
- Methods For Priming Allogeneic Cultured Keratinocyte Compositions For Topical Useapplication
- Tissue Container Systemsapplication
- Viable Bioengineered Allogeneic Cellularized Skin Constructs That Secrete Soluble Factors Associated With Regenerative Wound Healingapplication
- Use Of Human Skin Substitutes Expressing Exogenous IL-12 To Treat A Wound Bedgranted
- Engineered Skin Construct Overlay Of Autograftapplication
- Methods For Treating Acute Wounds And Improving Outcomesapplication
- Tissue Container Systemsapplication
- Tissue Container Systemsapplication
- Tissue Container Systemsgranted
- Cryopreservation Of Viable Human Skin Substitutesapplication
- Cryopreservation Of Viable Human Skin Substitutesgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.